Chaco, Joshua; Viskoper, Ruben J.
October 1971
Angiology;Oct1971, Vol. 22 Issue 9, p521
Academic Journal
Motor nerve conduction velocity testing was used to detect subclinical peripheral neuropathy in hypertension. The right ulnar and left median nerves of thirty patients with essential hypertension, but without diabetes or uremia, were examined. Neurological examination in all patients was normal. In 18 patients with diastolic pressures of less than 120, the MNCV was normal while in the remaining 12 with diastolic pressures of 120 or higher, abnormal MNCV rates, indicating subclinical peripheral neuropathy, were found.


Related Articles

  • Guidelines for the prevention and treatment of foot problems in diabetes.  // Journal of Endocrinology, Metabolism & Diabetes of South Africa;Mar2012, Vol. 17 Issue 1, pS68 

    The article offers information on the epidemiology, risk factors, and treatment strategies of patients with neuropathy, nonulcerative pathology, and ulcerated feet. It focuses on the morbidity and mortality associated with distal peripheral sensory diabetic neuropathy and its sequelae, and also...

  • Exploring Current and Emerging Treatment Strategies for Optimal Patient Outcomes in Painful Diabetic Peripheral Neuropathy. Abrahamson, Martin J. // Clinical Diabetes;Summer2006, Vol. 24 Issue 3, p7 

    The article discusses treatment strategies for optimal patient outcomes in painful diabetic peripheral neuropathy (DPN). Approximately 10% of patients with DPN suffer from persistent pain or sensory distortion. Painful DPN can interfere with patients' quality of life by impairing their general...

  • Neuropathy in experimental diabetes: an animal model. Jakobsen, J.; Lundbaek, K. // British Medical Journal;7/31/1976, Vol. 2 Issue 6030, p278 

    Presents a morphometric analysis of the common peroneal nerve in early experimental diabetes in rats. Reduction in the size of the axon; Impact of the reduced axon on the impaired motor reduction velocity found in diabetics; Comparison between the reduced axon and the myelin sheath.

  • Glycemic Control Is Related to the Morphological Severity of Diabetic Sensorimotor Polyneuropathy. Perkins, Bruce A.; Bril, Vera; Greene, Douglas A. // Diabetes Care;Apr2001, Vol. 24 Issue 4, p748 

    Provides information on a study which determined the risk factors for predicting distal diabetic sensorimotor polyneuropathy using fiber density on sural nerve biopsy. Research design and methods; Results; Conclusions.

  • Assessment of Auditory and Visual Reaction Time in Type 2 Diabetics--A Case Control Study. Niruba, R.; Maruthy, K. N. // Al Ameen Journal of Medical Sciences;2011, Vol. 4 Issue 3, p274 

    Background: Focussing on Type 2 diabetes a worldwide epidemic, we used visual and auditory reaction time as a tool to detect neuropathy a common complication of diabetes so that we could prevent further damage to nerves. Material and Methods: cases and controls were enrolled based on detailed...

  • What causes this? Sisodia, Gurudatt; Mistry, D. // Update;1/20/2005, Vol. 70 Issue 1, p83 

    The article reports that a 69-year-old, ex-smoker who suffers from type II diabetes, IHD and hypertension, presented with a 6-month history of an ulcer on the plantar surface of the right foot. The well-demarcated ulcer displays a "puched-out" appearance and has developed in a weight-bearing...

  • Double Trouble. Sowka, Joseph W. // Review of Optometry;9/15/2012, Vol. 149 Issue 9, p94 

    The article discusses neurologically related ophthalmic disorder cranial nerve (CN) VI palsy. It mentions a case of a 62 year old black man who was having a medical history of primary open angle glaucoma and was later on diagnosed with the CN VI palsy. It further discusses the demographic groups...

  • Medical Management of Diabetic Neuropathy. La Fontaine, Javier // Podiatry Management;Apr/May2007, Vol. 26 Issue 4, p243 

    The article offers information on the medical management of diabetic neuropathy. Based on the International consensus, diabetic neuropathy is defined as the presence of signs and symptoms of peripheral nerve dysfunction in people with diabetes after the exclusion of other causes. It describes...

  • Neuropathic Ulcers in the Diabetic Patient: A Marker for Death. Snyder, Robert J. // Podiatry Management;Apr/May2010, Vol. 29 Issue 4, p191 

    The article discusses the clinical implications of neuropathic foot ulcers in diabetic patients. Diabetic foot ulceration (DFU) is a serious medical condition which can lead to infection, the need for amputation and possibly even death. Risk factors associated with DFU include uncontrolled...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics